Press Releases

Press Releases

March 25, 2020
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif. , March 25, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody ® therapeutic technology platform, today
Additional Formats
March 16, 2020
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif. , March 16, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, today
Additional Formats
February 24, 2020
Bristol-Myers Squibb Advances CytomX Therapeutics’ Anti-CTLA-4 Probody Therapeutic BMS-986249 into Randomized Cohort Expansion (Part 2a) of Ongoing Clinical Trial
Expansion Phase to Evaluate CTLA-4-Directed Probody ®  Therapeutic in Combination with Opdivo ® in Metastatic Melanoma  Bristol-Myers Squibb also Advances BMS-986288 into a Separate Phase 1/2a Clinical Trial SOUTH SAN FRANCISCO, Calif. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc.
Additional Formats
February 20, 2020
CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results
-Teleconference Scheduled for February 27, 2020, at 5:00 p.m. ET- SOUTH SAN FRANCISCO, Calif. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics
Additional Formats
February 7, 2020
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif. , Feb. 07, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody ® therapeutic technology platform, today
Additional Formats
Displaying 11 - 20 of 22